Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare
Myriad Genetics Inc. Operating Income 2009–2025
Myriad Genetics Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Myriad Genetics Inc. operating income for the quarter ending March 31, 2026 was -30.7 M, a 5.86% increase year-over-year.
- Myriad Genetics Inc. operating income for the twelve months ending March 31, 2026 was -412.2 M, a 185.26% increase year-over-year.
- Myriad Genetics Inc. annual operating income for 2025 was -387.2 M, a 213.52% increase from 2024.
- Myriad Genetics Inc. annual operating income for 2024 was -123.5 M, a 52.02% decrease from 2023.
- Myriad Genetics Inc. annual operating income for 2023 was -257.4 M, a 83.07% increase from 2022.
- Myriad Genetics Inc. annual operating income for 2022 was -140.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Myriad Genetics Inc. Operating Income — FAQ
Myriad Genetics Inc. (MYGN) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Myriad Genetics Inc.'s operating income?
Myriad Genetics Inc. (MYGN) reported operating income of -$387M for fiscal 2025.
Where can I see MYGN's operating income history?
The chart and table above show Myriad Genetics Inc.'s operating income by year and by quarter, including the growth rate.